This cancer antiapototic situation can be secondary to the overexpression/hyperactivity of proton transporters [76,156], the MDR-promoting effects of the Bcl-2 family of proteins [12], a dysfunctional p53 or the elevating cell pH effect of different growth factors [17,19,22,23,165,166] (see above). Here, BCL2 is linked to cancer.